These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6306337)

  • 1. Differences in antibody production against mouse hepatitis virus (MHV) among mouse strains.
    Nakanaga K; Ishida T; Fujiwara K
    Lab Anim; 1983 Apr; 17(2):90-4. PubMed ID: 6306337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopathology of mouse hepatitis virus type 3 infection. Role of humoral and cell-mediated immunity in resistance mechanisms.
    Le Prevost C; Levy-Leblond E; Virelizier JL; Dupuy JM
    J Immunol; 1975 Jan; 114(1 Pt 1):221-5. PubMed ID: 163277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Liu MF; Ning Q; Pope M; Mosmann T; Leibowitz J; Ding JW; Fung LS; Rotstein O; Gorczynski R; Levy GA
    Adv Exp Med Biol; 1998; 440():415-23. PubMed ID: 9782309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and characterization of monoclonal antibodies to mouse hepatitis virus, MHV-NuU.
    Nakanaga K; Kitagawa T; Kiuchi Y; Makino S; Hayami M; Fujiwara K
    Nihon Juigaku Zasshi; 1985 Jun; 47(3):423-33. PubMed ID: 2993723
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rederivation of MHV and MEV antibody positive mice by cross-fostering and use of the microisolator caging system.
    Lipman NS; Newcomer CE; Fox JG
    Lab Anim Sci; 1987 Apr; 37(2):195-9. PubMed ID: 3037189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 4 deficiency increases disease and mortality after mouse hepatitis virus type 1 infection of susceptible C3H mice.
    Khanolkar A; Hartwig SM; Haag BA; Meyerholz DK; Harty JT; Varga SM
    J Virol; 2009 Sep; 83(17):8946-56. PubMed ID: 19553337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternally derived immune resistance to fatal diarrhea in infant mice due to mouse hepatitis virus.
    Ishida T; Fujiwara K
    Jpn J Exp Med; 1982 Oct; 52(5):231-5. PubMed ID: 6302350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of antigenic peptides derived from B-cell epitopes of nucleocapsid protein of mouse hepatitis virus for serological diagnosis.
    Asano A; Torigoe D; Sasaki N; Agui T
    J Virol Methods; 2011 Oct; 177(1):107-11. PubMed ID: 21810445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro splenic T cell responses of diverse mouse genotypes after oronasal exposure to mouse hepatitis virus, strain JHM.
    Smith AL; Winograd DF; de Souza MS
    Lab Anim Sci; 1991 Apr; 41(2):106-11. PubMed ID: 1658436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of the F(ab')2 fragments of monoclonal antibodies to mouse hepatitis virus.
    Nakanaga K; Yamanouchi K; Fujiwara K
    Adv Exp Med Biol; 1987; 218():365-71. PubMed ID: 2829547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice.
    Nakanaga K; Yamanouchi K; Fujiwara K
    J Virol; 1986 Jul; 59(1):168-71. PubMed ID: 3012115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxidase-labeled antibody technique for rapid detection of mouse hepatitis virus in cases of natural outbreaks.
    Carthew P
    J Infect Dis; 1978 Sep; 138(3):410-3. PubMed ID: 212490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.
    Suzuki R; Kohno H; Sugie S; Nakagama H; Tanaka T
    Carcinogenesis; 2006 Jan; 27(1):162-9. PubMed ID: 16081511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM.
    de Souza MS; Smith AL
    Lab Anim Sci; 1991 Apr; 41(2):112-8. PubMed ID: 1658437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice.
    Barthold SW; Smith AL
    Lab Anim Sci; 1990 Mar; 40(2):133-7. PubMed ID: 2157090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Mouse Strain on Equine Herpesvirus 9 Infection.
    El-Nahass E; El-Habashi N; El-Dakhly KM; Tsuchiya Y; Yanai T
    J Comp Pathol; 2017 Jul; 157(1):67-74. PubMed ID: 28735674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect ELISA and indirect immunofluorescent antibody assay for detecting the antibody against murine norovirus S7 in mice.
    Kitagawa Y; Tohya Y; Ike F; Kajita A; Park SJ; Ishii Y; Kyuwa S; Yoshikawa Y
    Exp Anim; 2010; 59(1):47-55. PubMed ID: 20224169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal antibodies protect immunoglobulin deficient neonatal mice from mouse hepatitis virus (MHV)-associated wasting syndrome.
    Gustafsson E; Blomqvist G; Bellman A; Holmdahl R; Mattsson A; Mattsson R
    Am J Reprod Immunol; 1996 Jul; 36(1):33-9. PubMed ID: 8831899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.